Bullboard - Stock Discussion Forum Geron Corp GERN

Alternate Symbol(s): GERNW

Healthcare Biotechnology

Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the... see more

Add To Watchlist

NDAQ:GERN - Post Discussion

Geron Corp > Geron Corporation Announces Appointment of Joseph Eid, M.D.

View:

Post by whytestocks on Nov 11, 2024 10:30pm

Geron Corporation Announces Appointment of Joseph Eid, M.D.

News; $GERN Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and DevelopmentGeron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development, effective today, November 11, 2024. In this role...GERN - Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development